Treatment of chronic heart failure by the use of resynchronization therapy
Abstract
Abstract: Chronic heart failure due to systolic dysfunction has been treated pharmacologically by the extensive use of ACE inhibitors, beta blockers, spyronolactone and digoksin improving morbidity, mortality and the quality of life as well as decreasing hospitalisation rate in the last decade. However, despite all the endeavors to optimize pharmacological treatment the mortality of the described syndrom remains unreasonably high and many patients suffer from severly expressed symptoms that considerably affect their quality of life. Thus, novel treatment modalities are being sought continuously and there is one, namely cardiac resynchronisation therapy which has gained increasing interest in the last couple of years.
Downloads
References
Gras D, Mabo P, Tang T, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of of the Medtronic Inc InSync Study. PACE 1998; 21: 2249–55.
Leclercq C, Cazeau S, Ritter P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000; 140: 862–7.
Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in heart failure. N Engl J Med 2002; 346: 1845–53.
Cleland JG, Coletta AP, Nikitin N, Louis A, Clark A. Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans. Eur J Heart Fail 2003;5:391–8.
Cleland JGF, Thackray S, Goodge L, et al. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 2002; 13: S73–91.
Moss AJ, Zareba W, Hall WY, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–83.
Hohnloser S, Heinz Kuck K, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481–8.
Bardy GH, Lee KH, Mark DB, et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl Med 2005; 352: 225–37.
Wilkoff BL, Cook JR, Epstein AE, et al. Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002; 299: 3115–23.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
